Would your patient benefit from a monoclonal antibody?

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

These unique agents may be the answer when other treatments fail or are intolerable for patients with asthma, atopic dermatitis, hyperlipidemia, osteoporosis, or migraine headaches.

Cite

CITATION STYLE

APA

Campbell, L. S., & Sbar, E. D. (2022). Would your patient benefit from a monoclonal antibody? The Journal of Family Practice, 71(8). https://doi.org/10.12788/jfp.0481

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free